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ABSTRACT Ndufaf5 (also known as C20orf7) is a mitochondrial complex I (CI) assembly fac-
tor whose mutations lead to human mitochondrial disease. Little is known about the function 
of the protein and the cytopathological consequences of the mutations. Disruption of Dic-
tyostelium Ndufaf5 leads to CI deficiency and defects in growth and development. The pre-
dicted sequence of Ndufaf5 contains a putative methyltransferase domain. Site-directed mu-
tagenesis indicates that the methyltransferase motif is essential for its function. Pathological 
mutations were recreated in the Dictyostelium protein and expressed in the mutant back-
ground. These proteins were unable to complement the phenotypes, which further validates 
Dictyostelium as a model of the disease. Chronic activation of AMP-activated protein kinase 
(AMPK) has been proposed to play a role in Dictyostelium and human cytopathology in mito-
chondrial diseases. However, inhibition of the expression of AMPK gene in the Ndufaf5-null 
mutant does not rescue the phenotypes associated with the lack of Ndufaf5, suggesting that 
novel AMPK-independent pathways are responsible for Ndufaf5 cytopathology. Of interest, 
the Ndufaf5-deficient strain shows an increase in autophagy. This phenomenon was also 
observed in a Dictyostelium mutant lacking MidA (C2orf56/PRO1853/Ndufaf7), another CI 
assembly factor, suggesting that autophagy activation might be a common feature in mito-
chondrial CI dysfunction.
INTRODUCTION
Mitochondrial diseases are complex disorders caused by mutations 
in either nuclear or mitochondrially encoded proteins. The patho-
logical outcome varies in severity and includes a wide range of neu-
rodegenerative and muscular disorders, including blindness, deaf-
ness, epilepsy, heart and muscle disease, diabetes, and cancer, 
among others (Wallace, 2010). A large proportion of mitochondrial 
diseases affect the first and largest complex of the respiratory chain, 
mitochondrial complex I or NADH:ubiquinone oxidoreductase (CI). 
This huge multimeric protein structure is formed by 44 subunits in 
mammalian cells and couples the oxidation of NADH to reduction 
of ubiquinone and the transport of four protons from the matrix side 
to the intermembrane space (Fearnley et al., 2007). The resulting 
proton gradient is also contributed to by complexes III and IV and 
allows the synthesis of ATP in complex V (Koopman et al., 2010).
Prokaryotes present a comparatively simple CI composed of 14 
core subunits, which are able to perform the essential biochemical 
reactions (Efremov et al., 2010). The presence of additional acces-
sory subunits in higher organisms might reflect the presence of ad-
ditional unknown functions (Hirst, 2011). Pathogenic mutations have 
been described affecting all core and some accessory subunits. The 
assembly of such a large structure is only partially understood and 
involves the function of many assembly factors (McKenzie and Ryan, 
2010; Nouws et al., 2012). Of interest, nine of them have been found 
to be mutated in CI disease: NDUFAF1–F4, C8orf38, ACAD9, 
FORXRED1, NUBPL, and Ndufaf5 (Ogilvie et al., 2005; Vogel et al., 
2005; Pagliarini et al., 2008; Sugiana et al., 2008; Gerards et al., 
2009; Hoefs et al., 2009; Saada et al., 2009, 2012; Calvo et al., 2010; 
Fassone et al., 2010; Haack et al., 2010; Nouws et al., 2010). Other 
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logue of the human C2orf56 (also known as PRO1853), a conserved 
protein of unknown function. Carilla-Latorre et al. (2010) showed 
that Dictyostelium and human cells deficient in this protein have a 
specific defect in CI activity and assembly. This mitochondrial defi-
ciency caused the expected defects in phototaxis and thermotaxis 
that could be rescued by AMPK inhibition but also displayed addi-
tional defects, which were AMPK independent, including impaired 
phagocytosis, pinocytosis, and growth. This highlights the complex-
ity of the mitochondrial cytopathology and more specifically that of 
CI disease (Francione et al., 2011).
Mutations in the assembly factor Ndufaf5 cause different 
mitochondrial syndromes. A family with homozygous missense 
mutation L229P was reported to suffer a lethal neonatal form of 
CI deficiency (Sugiana et al., 2008). Another pathogenic amino 
acid substitution (L159F) was found to cause Leigh syndrome in a 
Moroccan family (Gerards et al., 2009). Recently a new mutation 
(G250V) causing Leigh syndrome was described (Saada et al., 
2012). All of these mutations decrease CI activity and assembly, 
but little is known about the function of the protein and the 
mechanisms of the disease. Ndufaf5 has a predicted S-adenosyl-
methionine (SAM)–dependent methyltransferase domain, and 
thus a possible role of methylation in CI assembly has been pro-
posed but not yet tested experimentally.
Here we describe the first Ndufaf5 model of the disease in a 
simple experimental system. We generated a Ndufaf5-null mutant 
in Dictyostelium discoideum and investigated the relationship be-
tween the resulting phenotypes and AMPK in this model. Further-
more, site-directed mutagenesis in a critical amino acid from the 
predicted SAM-binding domain strongly suggests the presence of a 
functional methyltransferase domain. Recreation of pathogenic mu-
tations in Dictyostelium Ndufaf5 resulted in a loss-of-function of the 
protein, reinforcing the usefulness of this model. Finally, autophagy 
was tested and found to be overactivated in Ndufaf5- and MidA-null 
mutants, suggesting that mitochondrial complex I dysfunction has a 
wider effect on cellular homeostasis than expected.
RESULTS
Generation of an insertional mutant in Dictyostelium 
Ndufaf5
Mutations causing mitochondrial complex I disease have been de-
scribed in core and accessory subunits, as well as in a number of 
complex I assembly factors. One of these assembly factors, Ndu-
faf5, is an uncharacterized protein conserved during evolution from 
bacteria to humans (Supplemental Figure S1 and Supplemental 
Table S2). The phylogenetic profile of this protein resembles that of 
other complex I proteins, being present in alpha proteobacteria, the 
closest living organisms to the putative precursors of eukaryote mi-
tochondria, and in most eukaryotes, with the remarkable exception 
of the fermentative yeasts Saccharomyces cerevisiae and Schizosac-
charomyces pombe (Supplemental Table S2; Pagliarini et al., 2008). 
The Dictyostelium genome codes for a protein highly similar to the 
human Ndufaf5 (dictyBase ID: DDB_G0287769; Supplemental 
Figure S1 and Supplemental Table S2), with a Blast E-value of 6e-62. 
The National Center for Biotechnology Information conserved-do-
main database (Marchler-Bauer et al., 2011) predicts a SAM-depen-
dent methyltransferase motif in both the Dictyostelium and human 
proteins. Gene disruption in Dictyostelium was achieved by inser-
tional mutagenesis (Figure 1A). The resulting insertion of a blastici-
din-resistance cassette interrupted the gene in nucleotide 206 of 
the coding sequence at amino acid 69. As described in Figure 1, B 
and C, genomic PCR and reverse transcription-PCR (RT-PCR) analysis 
confirmed the isolation of disruptant strains, which showed no 
CI assembly factors have been described, but their involvement in 
human mitochondrial disease has not yet been documented, in-
cluding Ecsit (Vogel et al., 2007), MidA (also known as Ndufaf7, 
C2orf56, or PRO1853; Torija et al., 2006; Carilla-Latorre et al., 2010), 
and TMEM126B (Heide et al., 2012). Remarkably, CI dysfunction has 
also been associated with neurodegenerative diseases such as Par-
kinson and Alzheimer diseases (Janssen et al., 2006; Lazarou et al., 
2009; Sharma et al., 2009). Despite all these connections and impor-
tance in human pathology, many questions remain to be answered 
as to how such a variety of associated phenotypes arise and what 
their underlying cytopathological mechanisms might be.
The complexity of mitochondrial pathology has prompted the 
use of simple model systems. Dictyostelium, due to its similarities to 
mammalian cells and the presence of diverse, consistent, and read-
ily assayed phenotypes, has been developed as a model for 
mitochondrial diseases and other pathologies (Escalante, 2011; 
Francione et al., 2011). Dictyostelium is a social amoeba with two 
distinctive lifestyles: a motile unicellular stage, and a multicellular 
developmental stage, including relatively complex processes of cell 
differentiation and morphogenesis. The multicellular slug form is 
phototactic and thermotactic and after a variable period of migra-
tion gives rise to the terminal fruiting body composed of spores 
aloft a cellular stalk (Escalante and Vicente, 2000; Annesley and 
Fisher, 2009a).
Multicellular development in Dictyostelium takes place in the ab-
sence of nutrients, and thus autophagy, a “self-eating” mechanism 
to recycle the cell’s material, is essential for cellular homeostasis and 
development in this system as in all eukaryotes (Calvo-Garrido et al., 
2010). There are several types of autophagy, but the best known 
and the most conserved is macroautophagy (called just autophagy 
hereafter, for simplicity). Mechanistically, autophagy begins with the 
formation of a double-membrane vesicle called an autophagosome, 
which engulfs organelles or parts of the cytoplasm. This is followed 
by fusion of the autophagosome with lysosomes and the subse-
quent degradation of the vesicle and its contents. The simple mole-
cular constituents released during this degradation process can be 
recycled or used for ATP production. Autophagy is not only trig-
gered by starvation conditions such as nutrient or growth factor 
depletion, but it is also induced in circumstances requiring, for ex-
ample, the elimination of protein aggregates or defective organ-
elles or in response to bacterial pathogens (Ravikumar et al., 2010). 
Mitophagy—the specific degradation of mitochondria—has been 
implicated in diverse pathologies such as Parkinson disease (Rochet 
et al., 2012).
Different patterns of aberrant phenotypes occur as a result of 
mitochondrial dysfunction in Dictyostelium, including growth de-
fects, developmental abnormalities, and defects in phototaxis and 
thermotaxis (Bokko et al., 2007; Francione et al., 2011). Of interest, 
the Dictyostelium model has shown that several of these pheno-
types arise from abnormal signaling rather than from ATP insuffi-
ciency. Bokko et al. (2007) provided the first genetic evidence that 
the energy stress–sensing protein AMP-activated protein kinase 
(AMPK) is chronically activated in a Dictyostelium strain deficient in 
the mitochondrial protein chaperonin 60 (Hsp60), a protein mutated 
in hereditary spastic paraplegia (Hansen et al., 2002). Inhibition of 
AMPK expression in the Hsp60-deficient strain resulted in a sup-
pression of the aforementioned phenotypic defects. In addition, the 
growth, developmental, and photo/thermotaxis defects observed 
in this strain were phenocopied by overexpressing a constitutively 
active form of AMPK.
The consequences of a CI deficiency in Dictyostelium have been 
investigated in a MidA loss-of-function strain. MidA is the homo-
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(Figure 2B). To confirm this hypothesis, we 
performed viability experiments by count-
ing colony-forming units of spores plated in 
association with bacteria. The experiments 
showed a near-complete loss of spore via-
bility (<1%), in contrast with wild-type 
spores, which showed 90–100% viability.
The role of Ndufaf5 in CI is conserved 
between Dictyostelium and humans
Three different pathological mutations have 
been described in human ndufaf5. All of 
these missense mutations caused a strong 
defect in mitochondrial CI activity and as-
sembly. We wanted to determine whether 
Dictyostelium Ndufaf5 plays a similar role in 
this organism and can thus be used as a 
valid model of the disease. We first asked 
about the subcellular localization of the pro-
tein in Dictyostelium cells. To this end, the 
green fluorescent protein (GFP) was fused at 
the C-terminus of Ndufaf5 (named ndufaf5− 
rescue) and the construct transfected in the 
mutant background. The clones expressing 
the fused protein fully complemented the 
phenotypes described earlier (Supplemen-
tal Figure S2). Complementation confirms 
that the observed defects are exclusively 
caused by the genetic disruption of Ndufaf5 
and that the fused protein is functional. 
Confocal microscopy shows that Dictyostel-
ium Ndufaf5 is localized in mitochondria as 
described previously for the human protein 
(Figure 3A; Sugiana et al., 2008). Mito 
Tracker Red does not stain Dictyostelium 
mitochondria uniformly, being concentrated 
in spherical structures called submitochon-
drial bodies (van Es et al., 2001; Gilson et al., 
2003). Consequently, the merge images 
might show some green areas with little 
Mito Tracker Red staining. When the intensity of the red channel is 
increased the rest of the mitochondrion is visible and the colocaliza-
tion appears complete, as shown in the insets of Figure 3A.
We next measured mitochondrial respiratory chain activities in 
wild-type and ndufaf5− cells (Figure 3B). A significant CI-specific de-
fect was observed (40% activity of that of the wild type), whereas the 
rest of respiratory activities remained normal. These experiments 
confirm that Dictyostelium Ndufaf5 is a mitochondrial protein re-
quired for CI function and strongly suggest functional conservation 
during evolution. To further characterize the mitochondrial defect in 
Ndufaf5-null, we measured the enzymatic activity of citrate synthase 
(Krebs cycle enzyme anchored to mitochondrial inner membrane). 
This activity has been extensively used as a marker of mitochondrial 
mass and was found to be increased in the mutant strain, suggest-
ing the presence of a compensatory mechanism (Figure 3C, left). 
Surprisingly, we also found increased levels of total ATP in cells lack-
ing Ndufaf5 (Figure 3C, right).
Site-directed mutagenesis studies of the putative 
SAM-binding motif
The Conserved Domains Database (CDD) predicts a methyltrans-
ferase domain in Ndufaf5 from both humans and Dictyostelium, 
expression of ndufaf5 mRNA. All strains showed similar phenotypes, 
and one of these clonal isolates (ndufaf5−) was selected for the 
following studies.
The Ndufaf5-null mutant has pleiotropic defects in growth 
and development
Previous studies showed that mitochondrial defects in Dictyostelium 
result in defects in growth and development (Bokko et al., 2007; 
Carilla-Latorre et al., 2010). We first analyzed these phenotypes in 
the ndufaf5− strain. The null strain showed a significant defect in 
growth, both in association with bacteria (Figure 2A) and in HL5 ax-
enic medium. Generation time increased in axenic media to 14 h, 
compared with 10 h in the parental AX4 strain. For developmental 
analysis, cells grown in axenic media were deposited onto nitrocel-
lulose filters (Figure 2B). The ndufaf5− cells showed a delay in devel-
opment. At 24 h wild-type strains formed early culminants, whereas 
ndufaf5− structures remained at the finger/slug stage. After a longer 
incubation (48 h) the mutant eventually culminated, but the fruiting 
bodies were smaller than those of the wild type. Moreover, spores 
taken from the fruiting bodies after 10 d, a time necessary for full 
maturation, showed abnormal morphology under phase contrast 
microscopy, suggesting a defect in differentiation or maturation 
FIGURE 1: ndufaf5 disruption and loss of expression. (A) Scheme of the disruption vector and 
the disrupted gene after homologous recombination. The BsR cassette interrupted the gene at 
the nucleotide 206 of the coding sequence and deleted the intron (indicated as a V-shaped line). 
Open boxes represent ndufaf5 exons. Solid boxes represent the disruption vector with the 
position of the N and C-terminal fragments used to allow homologous recombination. The BsR 
cassette is located between the fragments and is not depicted in scale to allow the correct 
overlapping with the scheme of ndufaf5 locus. The arrowheads with numbers indicate the 
different oligonucleotides used for verification of the disruptant strains (Supplemental Table S1). 
(B) Genomic verification. DNA extracted from wild-type and knockout strains was subjected to 
PCR using oligos 1 and 2. The amplification band indicates that homologue recombination has 
taken place in the expected region. The unrelated gene (dictyBase ID: DDB_G0268840) was 
used as a PCR control. (C) Transcriptomic verification. RNA extracted from wild-type and 
knockout strains at 14 h of development was subjected to RT-PCR using oligos 3 and 4. The 
absence of amplification in the mutant strains indicates that the transcript has been disrupted. 
Differences in the size of the bands between DNA and RNA templates are due to the presence 
of a small intron in both ndufaf5 and the control (DDB_G0268840) genes. M, DNA marker.
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protein was able to restore normal growth in liquid medium and SM 
plates (Figure 4B). However, M1 was unable to complement the 
growth phenotypes, which were similar to those of the ndufaf5− mu-
tant. To ensure the lack of complementation was not due to an in-
correct targeting of M1, we carried out confocal studies showing 
that M1, like the wild-type protein, was located in mitochondria 
(data not shown). The lack of complementation strongly suggests 
that the putative methyltransferase domain is required for Ndufaf5 
function.
Pathogenic mutations in Dictyostelium Ndufaf5 lead 
to a loss-of-function phenotype
Three pathogenic mutations have been described in human Ndu-
faf5, leading to Leigh syndrome (L159F and G250V) and lethal neo-
natal disease (L229P). L159 and L229 are conserved in the Dictyos-
telium protein (corresponding to L165 and L235), whereas the third 
one is not (Supplemental Figure S1). These residues and their sur-
rounding amino acids are also conserved in bacterial homologues, 
suggesting that they must play a critical role in Ndufaf5 function. To 
test this hypothesis, we performed site-directed mutagenesis in the 
conserved residues homologous to those mutated in patients 
(L165F and L235P). The resulting mutated proteins were called M2 
and M3, respectively. As for M1, both proteins were fused to GFP 
and the constructs transformed into ndufaf5− cells. A complete fail-
ure to rescue the null-mutant phenotype was observed (Figure 4), 
suggesting a loss of function of the proteins. The lack of comple-
mentation in M2 and M3 could not be the consequence of an incor-
rect mitochondrial location of these proteins since both colocalized 
with the mitochondrial marker MitoTracker Red in mitochondria 
(data not shown). This result further supports the functional conser-
vation of Ndufaf5 and offers a very simple model with which to study 
several cytopathological aspects of Ndufaf5-associated disease.
AMPK does not govern the cytopathology 
of Ndufaf5-null mutant
Previous analyses performed in Dictyostelium mitochondrial dis-
eased models (e.g., in Hsp60-deficient cells) showed that a chronic 
activation of AMPK was responsible for nearly all the defective phe-
notypes. However, not all the phenotypes are equally affected by 
mitochondrial dysfunction, with growth and slug phototaxis and 
thermotaxis being more strongly affected (Bokko et al., 2007; 
Francione et al., 2011). Down-regulation of AMPK by the expression 
of an antisense construct was shown to effectively suppress those 
phenotypes (Bokko et al., 2007; Francione et al., 2011). To get a 
better understanding of the role of AMPK in Ndufaf5 deficiency, we 
analyzed the consequences of down-regulating the expression of 
AMPK on the phenotypes associated with the lack of Ndufaf5. 
Therefore we tested slug phototaxis in ndufaf5− and found a clear 
defect in both qualitative and quantitative experiments (Figure 5), 
which can be rescued by the expression of Ndufaf5 (ndufaf5− rescue 
strain). However, in contrast with other mitochondrial defects, knock-
down of AMPK did not rescue either the phototaxis (Figure 5) or the 
growth defects associated with Ndufaf5 deficiency (Supplemental 
Figure S2). These results suggest that the cytopathology of ndufaf5− 
is not caused by the chronic activation of AMPK as described for 
other mitochondrial lesions.
ndufaf5− and midA− strains show strong induction 
of autophagy
AMPK is a major regulator of cell metabolism (Mihaylova and Shaw, 
2011). Several anabolic and catabolic pathways are regulated by 
this kinase, including autophagy, a process by which cells degrade 
based on sequence and homology with other methyltransferases. 
Several putative catalytic residues in the SAM-binding domain are 
specified in the CDD prediction for Ndufaf5. The typical GxGxG 
sequence is conserved during evolution (Supplemental Figure S1). 
To advance in the knowledge of this protein, we selected the first 
glycine of the motif for site-directed mutagenesis (G86V) and named 
the resulting protein M1 (Figure 4A). Wild-type (ndufaf5− rescue) 
and M1 proteins were fused to GFP (for subcellular localization stud-
ies) and transfected in ndufaf5− mutant. The wild-type form of the 
FIGURE 2: Analysis of growth and development in ndufaf5−. 
(A) Wild-type and ndufaf5− cells were seeded on SM plates in 
association with K. aerogenes and grown for 5 d. The ndufaf5− strain 
showed a strong defect in the diameter of the clearing zone. Bar, 
1 cm. (B) Cells grown exponentially in axenic medium were harvested, 
washed with PDF buffer, and deposited onto nitrocellulose filters 
according to Materials and Methods. Photographs were taken at the 
indicated times. The mutant strain showed a delay at the finger-slug 
stage. Structures culminated after 48 h, and the fruiting bodies were 
smaller than those of wild type. Bar, 2 mm. Wild-type and mutant 
spores were taken from 10-d-old fruiting bodies and observed under 
phase contrast microscopy. Mutant spores were rounder and less 
refractive, suggesting loss of viability. Bar, 10 μm.
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GFP-Atg18. This marker allows the observa-
tion of autophagosome vesicles that appear 
as small, bright green puncta in the cyto-
plasm. In wild type, the number of autopha-
gosomes increases during starvation. Of in-
terest, both mutants showed a strong 
accumulation of autophagosomes even in 
growth conditions (Figure 6A). Similar re-
sults were found using the autophagic 
marker GFP-Atg8 (data not shown). Accu-
mulation of autophagosomes could be due 
to either an induction of autophagy or a 
block at later stages of maturation. To dis-
criminate between these possibilities, we 
performed an autophagic flux assay based 
on the proteolytic cleavage of an autophagic 
substratum. The level of free GFP was mea-
sured by Western blot in wild-type, ndufaf5−, 
and midA− cells expressing GFP-Tkt-1 as de-
scribed previously (Calvo-Garrido et al., 
2011). As shown in Figure 6B, both mutants 
showed a significant increase of free GFP 
levels compared with wild type, which con-
firms an increase of autophagic flux.
Some mitochondrial defects increase 
specific degradation of mitochondria (so-
called mitophagy; Mijaljica et al., 2010). Mi-
tophagy events can be detected by colocal-
ization of mitochondria with autophagic 
markers. Therefore wild type and ndufaf5− 
and midA− mitochondrial mutants trans-
fected with the marker GFP-Atg18 were 
stained with MitoTracker Red and analyzed 
by confocal microscopy. Most of the puncta 
did not colocalize with mitochondria, as 
shown in Supplemental Figure S3. We also 
stained mitochondria with 4′,6-diamidino-2-
phenylindole (DAPI), which is independent 
of mitochondrial membrane potential, and 
obtained similar results (Supplemental 
Figure S4), suggesting that the increase in 
autophagy is not due to an activation of mi-
tophagy but instead to an activation of bulk 
autophagy.
DISCUSSION
We have shown that Dictyostelium Ndufaf5, 
like the human homologue, is a mitochon-
drial protein required for CI function, which 
argues for functional conservation during 
evolution and validates Dictyostelium as a 
simple model in which questions regarding 
the molecular function of the protein and 
the cytopathology of Ndufaf5 deficiency 
can be addressed.
The molecular function of Ndufaf5 remains elusive, and al-
though a methyltransferase motif type I can be predicted by bioin-
formatics (Niewmierzycka and Clarke, 1999), no functional studies 
had been carried out. Our studies show that a conserved residue 
of the catalytic domain is essential for protein function and thus 
support the predicted hypothesis. Unfortunately the common 
methyltransferase motif type I does not give any clue about 
their components via lysosomes to maintain cellular homeostasis 
under stress conditions. We wanted to determine whether this ma-
jor pathway of degradation is affected in ndufaf5− and compare this 
with cells lacking MidA, another CI assembly factor, whose defi-
ciency leads to phenotypes that are partially dependent on AMPK, 
such as phototaxis and thermotaxis. To this end, we transfected 
wild-type, ndufaf5−, and midA− cells with the autophagic marker 
FIGURE 3: Functional conservation of Ndufaf5 and mitochondrial phenotypes in the ndufaf5− 
strain. (A) Ndufaf5-GFP was expressed in the mutant background and subcellular localization 
of the protein analyzed by confocal microscopy. The region marked was magnified below 
and the color intensity adjusted to allow a clearer visualization of mitochondria. Bar, 10 μm. 
(B) Activities of complexes I, II, III, and IV in ndufaf5− and wild-type cells were measured by 
spectrophotometric analyses and corrected by protein and citrate synthase activity and finally 
normalized against wild-type levels. (C) Citrate synthase and cellular ATP levels. Citrate synthase 
activity was measured by spectrophotometric analyses and normalized as before. ATP levels 
were measured using a bioluminescence assay and normalized vs. wild-type levels. NS, 
nonsignificant. **p < 0.01.
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Huynen, 2007). Similarly, the HOGENOM 
database includes Ndufaf5 homologues 
and BioC in the same gene family: 
HOG000265011 (Penel et al., 2009).
Taken together, these evolutionary stud-
ies seem to relate Ndufaf5 and BioC, sug-
gesting that Ndufaf5 could catalyze methyl 
transfer from SAM to malonyl esters or simi-
lar molecules. However, it has long been 
known that mammals cannot synthesize bio-
tin (vitamin H), a final product of the FAS-II 
pathway. Nonetheless, this pathway might 
be conserved in mammals for other pur-
poses, such as CI assembly directly through 
ACP acylated forms, or indirectly by synthe-
sizing unknown fatty acids that could be re-
quired for helping CI insertion and folding 
into the mitochondrial inner membrane. In 
addition, some other CI structural subunits 
and CI assembly factors have been related 
in different ways to lipid metabolism, such 
as NDUFAB1, ACAD9, and C8orf38 (Nouws 
et al., 2010; McKenzie et al., 2011; Zurita 
Rendon and Shoubridge, 2012).
Ndufaf5 and MidA exhibit similarities 
and differences in the context of CI function 
in Dictyostelium. Both null mutants have a 
CI-specific defect, which in both cases is as-
sociated with an apparent increase in mito-
chondrial mass, albeit more evident for 
ndufaf5− (68 vs. 30% increment in midA−; 
Carilla-Latorre et al., 2010). Strikingly, total 
ATP in ndufaf5− increased up to 60% com-
pared with the wild-type levels, whereas 
midA− cells showed the opposite behavior, 
with a decrease of 30% compared with wild 
type. Although normal levels of ATP have 
been measured in patients of some mito-
chondrial diseases, it is nevertheless sur-
prising that a mitochondrial defect could 
lead to an increase in the levels of ATP, al-
though this observation is not without precedent. Studies in 
Caenorhabditis elegans showed that mutations in the CI structural 
subunit NDUFB4, which render CI inactive, lead to a strong increase 
of cellular ATP to 300% of that of wild-type controls (Yang and 
Hekimi, 2010).
Several mechanisms can be envisioned to explain this compen-
satory phenomenon. The increase in mitochondrial mass might in 
part compensate for the reduced activity of CI, and the mitochon-
drial potential might also be supported by the entry of electrons 
into the respiratory chain at other points different from CI. A change 
in the metabolic equilibrium between anabolic and catabolic path-
ways might reduce the use of ATP while activating autophagy to 
degrade the cell’s proteins, lipids, and glycogen, which can then be 
used to fuel ATP-generating pathways and keep energetic homeo-
stasis within viable limits.
Despite the similarities in the phototaxis defect, which affects 
both Ndufaf5 and MidA mutants, the relationship of this pheno-
type with AMPK activity is different. Chronic activation of AMPK 
was previously shown to be responsible for the phototaxis and 
thermotaxis defects in midA− mutant, but growth defects were in-
dependent. However, AMPK is not responsible for the phototaxis 
putative substrates, which could be nucleic acids, proteins, lipids, 
or other small metabolites (Kagan and Clarke, 1994). Ndufaf5 
shows high similarity to the bacterial protein BioC (Supplemental 
Figure S1). Of interest, the putative SAM-binding domain and two 
residues that we showed to be essential for the function of the 
protein, which are also present in human patients (L159 and L229), 
are also conserved in the bacterial protein. It is thus tempting to 
consider the hypothesis of a functional conservation between 
these two proteins.
BioC is the enzyme that catalyzes the first step in biotin biosyn-
thesis (methylation of esterified malonyl) in bacteria, using the well-
characterized fatty acid synthesis pathway (FAS-II like), which is con-
served from bacteria to mitochondria (Hiltunen et al., 2009, 2010). 
Of interest, this pathway is used in mitochondria not only for the 
synthesis of many different fatty acids, but also to synthesize the 
lipid moiety of 3-hydroxy-myristoyl-acyl carrier protein (NADH dehy-
drogenase [ubiquinone] complex I assembly factor [NDUFAB1], 
SDAP), a CI subunit. Moreover, phylogenetic studies showed that 
the biotin biosynthesis pathway might have existed in the pro-
teobacterium after the endosymbiotic event, making the conserva-
tion of the pathway in actual mitochondrion possible (Gabaldon and 
FIGURE 4: Site-directed mutagenesis analyses. (A) Schematic representation of the constructs 
used for complementation or site-directed mutagenesis experiments. Ndufaf5 was fused to GFP 
and tandem affinity purification tag (TAP-tag) into the pDV-GFP-CTAP vector, where expression 
is directed under the control of actin-15 promoter. The V-shaped line represents an intron. M1 is 
the mutation in the predicted SAM-binding domain (see the text). M2 and M3 are the 
corresponding mutations to the pathogenic ones in human (M2 equivalent to L159F, and M3 
equivalent to L229P). (B) Wild-type and mutant constructs were transfected in ndufaf5− cells. The 
expressed proteins colocalized with MitoTracker Red in mitochondria to the same extent as 
depicted in Figure 3A (data not shown). Transfected cells were spread onto SM plates to test 
the size of the clearing zone after 5 d. The strain transformed with the wild-type protein 
(ndufaf5− rescue strain) complemented the growth phenotype completely, in contrast to the 
mutated forms, which showed similar defects as the parental ndufaf5−. Bar, 1 cm.
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interact with the NDUFB3 subunit (Sugiana et al., 2008) since this 
CI structural subunit has different methylations in His residues on 
its N-terminal region (Carroll et al., 2005). Our studies in Dictyoste-
lium do not support this hypothesis because phylogenetic analyses 
show that Ndufaf5 and NDUFB3 do not have the same phyloge-
netic profile: in Dictyostelium the former is conserved, whereas no 
homologous protein for the latter can be identified by sequence 
similarity in this organism. Furthermore, the CI subunit composition 
of Pichia pastoris has recently been characterized (Bridges et al., 
2010). Both proteins have homologues in this organism, but the 
NDUFB3 homologue lacks the N-terminal region bearing the 
methylated residues in mammals. It is thus unlikely that the bio-
chemical function of Ndufaf5 is to methylate NDUFB3. There is, 
however, a methylation event described in Arg-323 in the CI sub-
unit NDUFS2 (Wu et al., 2003), a protein with a similar phylogenetic 
profile to Ndufaf5 and MidA. This raises the possibility that Ndu-
faf5 methylates NDUFS2. However, since MidA was found previ-
ously to interact with NDUFS2, it is probable that the responsible 
methyltransferase is MidA rather than Ndufaf5 (Carilla-Latorre 
et al., 2010).
In the present work, high levels of autophagy induction and 
accumulation of autophagosomes have been observed in both 
or growth defects in ndufaf5− mutant, suggesting that AMPK is not 
activated in this background. This is in agreement with the high 
levels of ATP found in ndufaf5−, which should keep AMPK inactive. 
The differences observed between Ndufaf5- and MidA-deficient 
cells suggest that despite their common function in CI, they might 
act at different levels affecting CI activity or its regulation. Never-
theless we cannot rule out the possibility of additional, as-yet-un-
discovered roles of these proteins in other mitochondrial 
functions.
Yeast-two hybrid screening and pull-down experiments revealed 
the interaction of MidA with a CI subunit (NDUFS2; Carilla-Latorre 
et al., 2010). Unfortunately, a similar approach did not yield repro-
ducible results in Ndufaf5. It was proposed that Ndufaf5 might 
FIGURE 5: Phototaxis defects in ndufaf5− are not rescued by AMPK 
inhibition. (A) Qualitative experiments. Different colonies (slugs) were 
allowed to migrate under lateral light source. Pictures were obtained 
after 48 h of incubation at 21ºC and the slug trails represented (see 
Materials and Methods). The ndufaf5− slugs had a significant defect in 
phototaxis, which was rescued after transfection with the Ndufaf5 
wild-type protein (ndufaf5− rescue). However, no suppression of the 
mutant phenotype was observed in ndufaf5− cells expressing a 
different number of copies of an AMPK antisense construct. A 
representative AMPK-inhibited strain is shown, with the number of 
copies between brackets. (B) Quantitative experiments. Phototaxis 
accuracy (κ value) was calculated for all the indicated strains at 
different cell densities (see Materials and Methods). A clear defect 
was again observed in ndufaf5− migrating slugs. This defect was 
complemented by overexpression of Ndufaf5 (ndufaf5− rescue) but 
not suppressed by antisense inhibition of AMPK (number of copies of 
AMPKas construct in brackets). The error bars represent 90% 
confidence intervals. Lines of best fit were determined by the least 
squares method, fitting an exponential model (wild type and 
ndufaf5− rescue) or logarithmic model (ndufaf5− mutant and AMPK 
antisense strains derived from it). The choice of model was dictated 
by which provided the best fit by eye.
FIGURE 6: Autophagy is increased in ndufaf5− and midA− cells. 
(A) Labeling of autophagosomes. The indicated strains were 
transfected with the autophagosome marker GFP-Atg18. Cells were 
incubated in growth media or starvation conditions (PDF buffer). 
Representative images show maximum projections of confocal images 
covering the whole cell. Bar, 10 μm. (B) Autophagic flux. Strains 
transfected with the marker GFP-Tkt-1 growing in HL5 were 
incubated with 0 or 100 mM NH4Cl (left and right lanes, respectively) 
as described in Materials and Methods. Extracts containing the same 
protein load were subjected to SDS–PAGE, transferred by Western 
blot, and incubated with α-GFP antibody to detect GFP-Tkt-1 and the 
cleaved GFP proteins. Left, a representative image of Western blots. 
Right, quantification of the ratio between free GFP and GFP–Tkt-1 of 
three independent experiments. *p < 0.05.
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ATP measurements and mitochondrial enzyme activities
For ATP measurements 5 × 106 wild-type or ndufaf5− cells grown in 
HL5 medium were washed and resuspended in water to a final vol-
ume of 1 ml. A 900-μl amount was mixed with 100 μl of trichloro-
acetic acid 10% in H2O and vortexed for 10 min. After centrifugation 
(10,000 × g, 5 min) the ATP content was measured in the superna-
tant using the ATP Determination Kittime-stable assay (Proteinkinase.
de, Biaffin, Kassel, Germany). The luminescence was measured in a 
GloMax96 luminometer (Promega, Madison, WI). Respiratory en-
zyme activities and citrate synthase activity were measured as previ-
ously described (Tiranti et al., 1995; Carilla-Latorre et al., 2010; 
Rodenburg, 2011).
GFP expression, mitochondrial labeling, and confocal 
microscopy
Dictyostelium C20orf7 was amplified from genomic DNA and 
cloned into pGEM-T Easy vector (Promega). The fragment was sub-
sequently cloned into pDV-CGFP-CTAP vector (GeneBank: 
EF028672), where the expression of the gene is under the control of 
the actin-15 promoter. Thereby, a C-terminal C20orf7-GFP fused 
protein was expressed in the indicated strains. For mitochondrial 
labeling 1 × 106 cells transfected with the aforementioned construct 
were incubated in HL5 (ForMedium) at 22ºC for 1 h with 500 nM 
MitoTracker Red CMXRos (Molecular Probes, Eugene, OR). After 
washing for 1 h with fresh HL5 medium, cells were deposited on 
a microscope coverslip and fixed with 3.7% formaldehyde in HL5 
for 15 min. After washing with phosphate-buffered saline (PBS; 
136 mM NaCl, 2.7 mM KCl, 10,1 mM Na2HPO4, 1.8 mM KH2PO4), 
they were mounted with Prolong (Molecular Probes) and analyzed 
by confocal microscopy. Confocal microscopy was performed using 
a Zeiss LSM 710 laser-scanning microscope (Zeiss, Jena, Germany) 
with a Plan-Apochromat 63×/1.40 objective. Software Zen 2009 and 
Photoshop CS (Adobe, San Jose, CA) were used to process all 
images.
Site-directed mutagenesis
Amino acid substitutions G86V, L165F, and L235P were performed 
by PCR using the oligonucleotides listed in Supplemental Table S1 
containing the desired mutations. The template was ndufaf5 cloned 
in pGEM-T Easy (see earlier description). After the PCR the DNA 
was digested with DpnI enzyme, and after purification it was trans-
formed into DH5α bacteria for cloning. The DNA was extracted by 
miniprep, and the mutations were confirmed by sequencing. The 
fragments were then cloned in pDV-CGFP-CTAP as previously de-
scribed for the wild-type gene. The constructs were transformed 
into ndufaf5− cells, and the resulting stably transformed strains were 
analyzed for growth in liquid (HL5) and SM plates. Mitochondrial 
localization of the mutated proteins was analyzed by laser confocal 
microscopy as described.
Phototaxis
Qualitative and quantitative experiments for slug phototaxis were 
carried out with wild-type and ndufaf5− slugs as previously described 
(Darcy et al., 1994; Carilla-Latorre et al., 2010). AMPKas transfection 
and copy number quantification were done as before (Bokko et al., 
2007).
Autophagy analyses
For analysis of autophagosomes, wild-type, ndufaf5−, and midA− 
cells were transfected with a construct expressing the autophagic 
marker GFP-Atg18 described previously (King et al., 2011). After 
hygromycin selection, cells were kept in HL5 medium and visualized 
Ndufaf5- and MidA-null mutant strains. This is the first time that in-
duction of macroautophagy has been demonstrated in a CI disease 
model. Besides starvation, autophagy can be activated by a variety 
of cellular stresses, including protein aggregation, endoplasmic re-
ticulum stress, DNA damage, reactive oxygen species, and micro-
bial pathogens. Several signaling pathways have been implicated in 
the induction of autophagy, including AMPK, TorC1, and the class III 
phosphoinositide 3-kinase (PI3K). If AMPK were responsible for au-
tophagic induction in Dictyostelium, differences would have been 
expected between the two mutants since only midA− and not ndu-
faf5− cells seem to have chronic activation of AMPK as determined 
by recovery experiments after AMPK knockdown. Of interest, ge-
nome-wide screening with a small interfering RNA library in human 
neuroblastoma cells showed that inhibition of several proteins could 
induce bulk autophagy in a manner dependent on PI3K (Lipinski 
et al., 2010). Some of these proteins, such as the complex IV subunit 
COX5A, were located in mitochondria, implicating directly an oxi-
dative phosphorylation defect in autophagic induction (Lipinski 
et al., 2010). More work is needed to determine the signaling path-
ways and the mechanisms of bulk autophagy regulation in response 
to mitochondrial dysfunction.
In conclusion, we described the first model for Ndufaf5 defi-
ciency in a simple eukaryote. The lack of Ndufaf5 or the expression 
of proteins carrying pathogenic mutations leads to a loss-of-function 
phenotype involving AMPK-independent phenotypes in growth 
and development. In addition, we described unexpected connec-
tions between CI deficiency and cellular homeostasis mechanisms 
such as autophagy that should be considered in future studies as 
new players in the cytopathology of the mitochondrial disease.
MATERIALS AND METHODS
Dictyostelium growth, transformation, and development
Dictyostelium AX4 cells were grown in HL5 medium (ForMedium, 
Hunstanton, United Kingdom) or in association with Klebsiella aero-
genes (SM plates) as previously described (Sussman, 1987). Trans-
fections were carried out as previously described (Pang et al., 1999). 
For synchronous development, Dictyostelium cells growing in HL5 
medium were centrifuged, resuspended in PDF buffer (20 mM KCl, 
9 mM K2HPO4, 13 mM KH2PO4, 1 mM CaCl2, 1 mM MgSO4, pH 
6.4), and deposited onto nitrocellulose filters (Shaulsky and Loomis, 
1993). Spore viability was measured as described before (Eichinger 
and Rivero, 2006).
Disruption of ndufaf5
For the disruption construct, N- and C-terminal fragments 
from Dictyostelium ndufaf5 gene were generated by PCR using 
Dictyostelium AX4 genomic DNA and sequentially cloned at ei-
ther side of a blasticidin-resistance (BsR) cassette derived from 
pUCBsrBam vector (Adachi et al., 1994). The insertion of the BsR 
cassette by homologous recombination interrupted the gene at 
the coding nucleotide 206, which corresponds to the encoded 
amino acid 69, located 10 nucleotides upstream of the small in-
tron of the gene. Because the C-terminal fragment begins at the 
encoded amino acid 85, a small deletion of 16 amino acids was 
created, which would also generate a frameshift. After transfection 
of wild-type AX4 cells and BsR selection, cells were plated on SM 
plates for clonal isolation and screened for homologous recombi-
nation into the target gene. To verify the absence of Ndufaf5 
mRNA, RNA was isolated from wild-type and mutant strains 
(developed for 14 h) using TRIzol Reagent (Sigma-Aldrich, St. 
Louis, MO) and used in RT-PCRs with the oligonucleotides indi-
cated in Supplemental Table S1.
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by confocal microscopy as described. Z-stacks were selected to 
get maximum projections covering the whole cell. For starvation, 
cells grown in HL5 were washed two times and incubated for 1 h 
in PDF buffer and visualized as before. For mitophagy experiments, 
Atg18-GFP–transfected cells growing in HL5 medium were incu-
bated for 1 h with MitoTracker Red CMX Ros and treated as be-
fore. For DAPI staining, cells were allowed to attach to a coverslip 
and fixed with 3% paraformaldehyde in PBS. After three washes 
with PBS, cells were stained with 1 μg/ml DAPI (Sigma-Aldrich) for 
5 min and mounted for confocal microscopy as described.
Autophagic flux was measured as before (Calvo-Garrido et al., 
2011). Briefly, GFP-Tkt-1–transfected cells growing in HL5 were 
washed and resuspended in fresh HL5 medium to a final concentra-
tion of 1 × 106 cells/ml. NH4Cl was added to a concentration rang-
ing from 0 to 100 mM to slow down the autophagic kinetics, allow-
ing degradation of GFP-Tkt-1 to be observed as previously published 
(Calvo-Garrido et al., 2011). After 2 h, NH4Cl was added again for an 
additional 2 h (4 h total incubation). Cells were collected by centrifu-
gation and resuspended in RIPA buffer. The protein content was 
quantified using the Bradford assay (Bio-Rad, Hercules, CA). A 3.5-
μg amount of protein was loaded onto a 12% SDS–PAGE gel. After 
blotting to a polyvinylidene fluoride membrane, GFP and GFP-Tkt-1 
were detected with α-GFP antibody (Sigma-Aldrich).
Statistical analysis
Except where otherwise specified, results are shown as mean values 
with SD from at least three independent experiments. The signifi-
cance of differences between groups was determined using the 
Student’s t test. Phototaxis was analyzed using directional statistics 
based on the von Mises distribution as previously described 
(Annesley and Fisher, 2009b).
Bioinformatics analysis
Ndufaf5 protein sequences from humans D. discoideum and a 
representative group of homologues in α, β, and γ-proteobacteria 
(19 proteins), obtained previously using Blast, were aligned using 
ClustalW2 (Larkin et al., 2007) and displayed with Jalview 
(Waterhouse et al., 2009). The alignment was curated with Jalview, 
eliminating extended gaps and N- and C- terminal residues for the 
next-step analysis. A phylogenetic tree using distance matrix 
methods (neighbor joining) was generated with ClustalW2 (Larkin 
et al., 2007).
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